A recent report, which examined the AhR-mediated impact of IDO activation on immunosuppressive functions, such as LPS tolerance and immune escape of cancer cells, offers new insights for a better understanding of the development of cellular dysfunctions in immunoparalysis. This evidence concerns the gene IDO1 and cancer.